Brought to you by 
3M to buy Acelity; enterprise value $6.7bn
14 Oct 2019
Executive Summary
3M & Co. will acquire wound care firm Acelity LP and its KCI subsidiaries from an investor consortium led by Apax partners for a total enterprise value of $6.7bn ($4.4bn cash plus assumption of net debt).
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
3M to buy Acelity; enterprise value $6.7bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice